Multiple Benefits Of Microbiome-Based Skin Products Is Driving The Microbiome Industry

Microbiome Market 2021 - Opportunities And Strategies – Forecast To 2030

Microbiome Market 2021 – Opportunities And Strategies – Global Forecast To 2030

The Business Research Company’s Microbiome Market 2021 – Opportunities And Strategies – Global Forecast To 2030

LONDON, GREATER LONDON, UK, November 23, 2021 /EINPresswire.com/ — The usage of microbiome-based skin products is a driver for the microbiome market. The increased environmental stressors, pollution, and fear of chemicals, is driving consumers towards microbiome-based skincare. The skincare market has embraced distinct approaches, targeting the skin microbiome such as probiotics, prebiotics, postbiotics. These products help in anti-aging of skin by improving the quality of skin, accelerating its renewal process, and supporting the shedding of dead skin cells. Microbiome-based cosmetics can also help prevent dandruff, acne, psoriasis, or atopic dermatitis. The multiple benefits of microbiome based cosmetic products is promoting the use of these products.

The global microbiome market size reached a value of nearly $4.98 billion in 2020, having increasing at a compound annual growth rate (CAGR) of 12.6% since 2015. The market is expected to grow at a CAGR of 12.7% from 2020 to reach $9.06 billion in 2025. The market is expected to reach $15.55 billion in 2030, at a CAGR of 11.4%.

TBRC’s holiday sale has begun with discounts on ALL market research reports! Grab your deal now.

Companies in the microbiome market are strategically partnering and collaborating with other companies to broaden their product portfolios and expand their microbiome therapeutics business. For instance, in November 2019, Enterome, a France-based leading player in the microbiome market entered into collaboration with Memorial Sloan Kettering Cancer Canter (MSK), a US-based research institute to develop cancer immunotherapies from gut microbiome-derived antigens. Also, in 2018, Microbiotica, a leading player in the market entered into a collaboration with Genentech to develop microbiome therapeutics to treat inflammatory bowel disease.

Read More On The Global Microbiome Market Report:
https://www.thebusinessresearchcompany.com/report/microbiome

Major players covered in the global microbiome industry are Assembly Biosciences, Enterome Bioscience, Ferring Pharmaceutical, Vedanta BioSciences, Seres Therapeutics.

Asia-Pacific was the largest region in the global microbiome market, accounting for 37.2% share of the total in 2020. It was followed by North America, Western Europe, and then the other regions. Going forward, the fastest-growing regions in the microbiome market will be South America and Africa.

TBRC’s global microbiome market report is segmented by type into fecal microbiota transplantation (FMT), microbiome drugs, by application into inflammatory bowel disease, diabetes, multiple sclerosis, rheumatoid arthritis, others, by technology into genomics, proteomics, metabolomics.

Microbiome Market 2021 – By End Use Industry (Human Therapeutics, Human Diagnostics, Agriculture & Environmental, Food & Feed), By Type (Microbial Drugs, Fecal Microbiota Transplantation), By Application (Infectious Diseases, Cancers, Gastrointestinal Disorders, Metabolic Diseases) And By Region, Opportunities And Strategies – Global Forecast To 2030 is one of a series of new reports from The Business Research Company that provides microbiome market overview, forecast microbiome market size and growth for the whole market, microbiome market segments, and geographies, microbiome market trends, microbiome market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Microbiome Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4064&type=smp

Here Is A List Of Similar Reports By The Business Research Company:

Microbiome Therapeutics Global Market Report 2020 – By Product (Probiotics, Prebiotics, Symbiotics), By Application (Inflammatory Bowel Disease, Diabetes, Multiple Sclerosis, Rheumatoid Arthritis), By Distribution Channel (Hospital Pharmacies, Drug stores, Retail Pharmacies, E-commerce stores)
https://www.thebusinessresearchcompany.com/report/microbiome-therapeutics-global-market-report

Human Microbiome Therapeutics Market – By Disease (Infectious Diseases, Gastrointestinal Disorders, Metabolic Disorders, Cancers), By Sequencing Technology Type (Targeted Gene, RNA, Whole-Genome Shotgun (WGS)) And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/human-microbiome-therapeutics-market

Genomics Global Market Report 2021 – By Product Type (Instrument (Including Systems, Service Contract And Software), Reagents (Including Reagents And Consumables)), By Process (Cell Isolation, Sample Preparation, Genomic Analysis), By End User (Academic Institutes, Biopharmaceutical Companies, Clinical Research Institutes), COVID-19 Growth And Change
https://www.thebusinessresearchcompany.com/report/genomics-market-global-report

Interested to know more about The Business Research Company?
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Or get a quick glimpse of our services here: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

The Business Research Company
Email: info@tbrc.info
Follow us on LinkedIn: https://bit.ly/3b7850r
Follow us on Twitter: https://bit.ly/3b1rmjS
Check out our Blog: http://blog.tbrc.info/

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire